Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT01289171Not ApplicableCompleted

Acquired Epidermodysplasia Verruciformis (EV) Syndrome in HIV-infected Pediatric Patients

Role: collaborator

NCT00769184Not ApplicableCompleted

Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

Role: lead

NCT00708851Not ApplicableCompleted

NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study

Role: lead

NCT02286700Phase 3Unknown

Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis

Role: lead

NCT00705900Not ApplicableCompleted

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

Role: lead

All 5 trials loaded